Fundraising FoxMatū
Venture capitalAuckland · Pre-Seed–Growth · 24 people tracked
Find your way into Matū
Investment thesis
Matū operates venture capital funds focused on science and deep tech companies in Aotearoa New Zealand. It takes a hands-on, active approach, backing researchers and founders working on real-world solutions to global challenges. The firm aims to turn ground-breaking scientific ideas into globally focused, IP-rich companies, drawing on decades of combined commercial and scientific experience. Portfolio companies receive strong governance, strategy, IP, and capital-raising expertise, plus access to domain experts connected to the global scientific and academic community. Matū frequently syndicates investments alongside other professional investors to reduce risk and broaden networks.
Source: firm website, verified Sep 27, 2026.
Team · 24 people
from the firm's website
What they invest in
from 7 of 20 portfolio companiesHealthtech ×4Biotech ×3AI & Machine Learning ×2Cleantech ×2Medical Devices ×2New Materials ×2Climate Tech ×1Deep Tech ×1
HQs:New Zealand×5Australia×1United States×1
Investments · 20 tracked
founders shown can be your intro path
Alimetry develops the Gastric Alimetry system, a non-invasive body surface gastric mapping device that provides objective diagnostics for patients with chronic gastrointestinal symptoms.
AI & Machine LearningDigital HealthHealthtechMedical DevicesAuckland, NZ
Greg O'Grady(Co-founder & Chief Executive Officer)inArmen Gharibans(Co-founder & President, US)inKaren O'Regan(CBO)inCraig Shannon(CTO)inChristie Dunwoodie(CFO)inChristopher Andrews(CMO)
Co-investorsBooster Innovation FundCerity Partners VenturesGD1MovacOlympus Innovation VenturesIcehouse Ventures
Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic.
BiotechHealthtechMedical Devices
Benjamin Thierry(Scientific Advisor/Founder)inStewart Bartlett(CEO)inAnil Shetty(CMO)in
Co-investorsArtesianSouth Australian Venture Capital FundBooster Innovation FundStoic VCUniSeed Pty Ltd.
Inhibit Coatings develops antimicrobial coatings and additives that use silver permanently bound to polymer resin to inhibit bacterial growth without leaching.
CleantechHealthtechNew MaterialsWellington, NZ
Dr Tate(Co-creator of the technology)Prof. Johnston(Co-creator of the technology)
Co-investorsAngel HQArc AngelsBooster Innovation FundEnterprise AngelsIcehouse VenturesNZ Growth Capital Partners
Liquium develops a new catalyst technology for producing clean (zero-carbon) ammonia under milder operating conditions than the traditional Haber-Bosch process, aiming to lower production and operating costs.
CleantechClimate TechNew Materials
Dr Franck Natali(CSO & Co-Founder)Dr Paul Geraghty(CEO & Co-Founder)
Co-investorsBooster Innovation FundClimate Venture Capital Fund
Opo develops bio-based ingredients and cell lines for cosmetic, medical, and cultivated meat applications using synthetic biology and biomanufacturing.
BiotechDeep TechFoodTechAuckland, NZ
Co-investorsBooster Innovation FundWNT VenturesEpic Angels
Commercialising soft electronics technology for robotics applications.
Co-investorsBooster Innovation FundNZ Growth Capital PartnersPacific Channel
RosterLab provides AI-powered staff scheduling software that automates the creation of complex work rosters for healthcare and other organizations.
AI & Machine LearningEnterprise SoftwareHealthtechHR TechSaaSAuckland, NZ
IsaacDanielSunny
Co-investorsMovacPacific ChannelQuidnet Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AdvemtoAmaeaAmpersand TechnologiesCaptivateCAS (Codify Asset Solutions)CAS (Codify Solutions)ChitogelCodify Asset SolutionsHtsHTS-110MEKONOSRekover TherapeuticsSynthase Biotech
Portfolio news
latest coverage across their companiesFerronova · ferronova.com.au · Dec 17, 2025
Frequently asked questions
- How many investments has Matū made?
- Matū has 20 tracked investments.
- What stage does Matū invest at?
- Matū invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Matū focus on?
- Matū focuses on AgTech, AI & Machine Learning, Biotech, Cleantech, Deep Tech, Medical Devices, New Materials.
- Where is Matū located?
- Matū is headquartered in Auckland, NZ.
- Who does Matū co-invest with?
- Matū most often shares deals with Booster Innovation Fund, Movac, NZ Growth Capital Partners, among 17 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Ontario Centre of Innovation (OCI) is a government-funded organization that helps Ontario innovators connect with researchers, industry partners and funding to commercialize made-in-Ontario intellectual property and technologies.
Kyoto University Innovation Capital (Kyoto iCAP) is a venture capital firm wholly owned by Kyoto University, established in December 2014 to commercialize research and technology developed by the university's researchers.
Miyako Capital is an independent private venture capital firm founded in 2013 that partners with Kyoto University and invests in R&D-driven, technology startups spinning out of academia and research institutions.